Skip to Content for Wai Lee Wong Menu for Wai Lee Wong About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

Wai Lee Wong

Wai Lee Wong

Wai Lee Wong Director: Assay & Automation Technology

Profile | Education/Background | Top Scientific Papers

"I was attracted to Genentech because of its reputation as a great place to do cutting-edge science leading to the development of new therapeutics. Since joining Genentech in December 1987, I have found that not only do I get to develop new assay techniques, but I also get to use them for various challenging and exciting scientific investigations with a group of extremely motivated and highly collaborative people."

Current Projects "Members of the department are involved in a number of early- to late-stage research projects in the areas of oncology, immunology, and vascular biology. The majority of our efforts are focused on developing critical and innovative biochemical and cell-based assay technologies needed to advance projects. We also develop automated systems to perform high throughput assays and manage assay results."

Collaborations "One of the most rewarding projects I have had the opportunity to participate in, from early research to final product, is Herceptin® (Trastuzumab). I worked with scientists like Paul Carter and Len Presta on the humanization of the Herceptin antibody by developing different assays. I particularly enjoyed collaborating with very committed scientists from Research, Regulatory and Clinical on obtaining FDA approval of a diagnostic test for enrolling patients for Herceptin therapy. Currently, I am involved in enhancing the efficacy of anti-tumor antibodies and establishing high throughput assays in support of pharmacokinetic studies and cell line development."

Inspiration/Vision "I am inspired by the knowledge that I am developing novel assays necessary for the advancement of projects. I am further energized by the fact that I am collaborating with highly intelligent individuals who are committed to furthering our knowledge of the molecules under investigation. Over the next five years, I hope the assay techniques established by our department will result in the development of novel and important drugs that can benefit individuals and society in a significant way."